A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Arcapta Neohaler (Indacaterol Maleate)
Brand
Arcapta Neohaler (Indacaterol Maleate)
Prescription Required
Strength
Qty
You'll have option to make 4 interest-free payments by credit card once your order is confirmed using
We don't have this generic product yet!
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Arcapta Neohaler is a prescription inhaler that can be used for the long-term management of symptoms of Chronic Obstructive Pulmonary Disease (COPD). COPD includes the conditions chronic bronchitis and emphysema.
Arcapta Neohaler is a long-acting beta-agonist (LABA) that expands the lungs for easier oxygen and carbon dioxide (gas exchange). LABA medications work by relaxing the smooth muscles of the lungs.
Arcapta is no longer available for purchase in pharmacies in the United States.
Fact Table
Formula
C24H28N2O3
License
US FDA, EU EMA
Bioavailability
43-45%
Legal status
Rx-only
Chemical Name
Indacaterol
Elimination half-life
More than 30 h
Dosage (Strength)
75mcg
Pregnancy
Consult Doctor
Brands
Onbrez, Arcapta
Protein binding
94.1-95.3%
PubChem CID
6433117
MedlinePlus
a612014
ChEBI
68575
ATC code
R03AC18
DrugBank
DB05039
KEGG
D09318
Routes of administration
Inhalation
Directions
Arcapta Neohaler is a powdered inhalation. Do not swallow the capsules. Only use the Neohaler to administer the medication.
The standard dosage is 75 mcg inhaled by mouth once daily while using the Neohaler.
This medication must be taken daily to be effective.
Ingredients
The active ingredient in Arcapta Neohaler is indacaterol.
Interactions
Arcapta Neohaler has many potential drug-drug interactions. Tell your doctor and pharmacist if you are taking:
Atomoxetine
Atosiban
Beclomethasone
Budesonide
Caffeine
Cannabinoid products
Carvedilol
Ciclesonide
Flunisolide
Fluticasone
Guanethidine
Haloperidol
Labetalol
Linezolid
Loop diuretics
Loxapine
Methacholine
Mometasone
Monoamine oxidase inhibitors
Nadolol
Penbutolol
Pindolol
Propranolol
QT-prolonging agents
Sotalol
Theophylline
Timolol
Topical cocaine
Tricyclic antidepressants
Cautions
Do not use Arcapta Neohaler to treat asthma or asthma symptoms.
Arcapta Neohaler is not a treatment for acute symptoms of COPD. A short-acting beta-agonist like albuterol should be used for this purpose.
Do not blow into the inhaler when using it.
Do not take more than is prescribed by your healthcare provider.
Tell your doctor if you have a history of cardiovascular or thyroid conditions.
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Prescription Required
